Related references
Note: Only part of the references are listed.Engineering H5N1 avian influenza viruses to study human adaptation
David M. Morens et al.
NATURE (2012)
IFITM3 restricts the morbidity and mortality associated with influenza
Aaron R. Everitt et al.
NATURE (2012)
The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection
Yonghong Zhang et al.
ANTIVIRAL RESEARCH (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China
Cuiling Xu et al.
PLOS ONE (2011)
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
Eric M. Feeley et al.
PLOS PATHOGENS (2011)
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
I-Chueh Huang et al.
PLOS PATHOGENS (2011)
Interferon-Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular Stomatitis Virus Infection via Distinct Mechanisms
Jessica M. Weidner et al.
JOURNAL OF VIROLOGY (2010)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
Share Paper
